As assessed by lysates, ALP content increased in BMP6-treated MMs at each successive 2-week interval relative to d0 reference samples, while ALP in control OM cultures remained relatively constant over the 6-week induction period (Fig. 6A; n = 6; p < 0.01). The gene discussed is BMP6; the disease is ocular melanoma.